Phospholamban (PLB) is a major target of β-adrenergic signaling, whose phosphorylation results in enhanced rates of relaxation in the heart. Prior to phosphorylation, PLB functions to reduce the calcium sensitivity of the Ca-ATPase, resulting in slower rates of calcium resequestration into the sarcoplasmic reticulum after each contractile event. Recent structures indicate that the inhibitory interaction between PLB and the Ca-ATPase requires PLB to assume an extended structure, where the transmembrane and cytosolic portions of PLB undergo specific binding interactions with distant sites on the Ca-ATPase. In the extended conformation, PLB binding to the Ca-ATPase functions to inhibit the Ca-ATPase through a reduction in the rates of catalytically important motions involving the nucleotide binding domain. Phosphorylation of PLB at either Ser 16 or Thr 17 releases the inhibitory interaction between PLB and the Ca-ATPase. These sites of phosphorylation are within a hinge region in PLB that separates the highly structured transmembrane and cytosolic portions that associate with the Ca-ATPase. The helical content of the hinge region increases following the phosphorylation of PLB, which induces a shortening of the maximal dimensions of PLB and a release of the inhibitory interaction with the Ca-ATPase. Following phosphorylation, PLB remains associated with the Ca-ATPase in a more compact form that has no inhibitory capability. Thus, the conformational switch involving PLB regulation of the Ca-ATPase relies upon a physical mechanism, whereby the phosphorylationdependent stabilization of the structure of PLB functions to destabilize the inhibitory interaction between PLB and the Ca-ATPase. Upon hydrolysis of the phosphoester linkages by endogenous phosphatases, PLB is poised to reassume the inhibited state through re-association with inhibitory sites on the nucleotide binding domain of the Ca-ATPase.
PHYSIOLOGICAL ROLE OF PLBPhospholamban (PLB) is a 52 amino acid integral membrane protein that constitutes a key element in the responsiveness of muscle contractility to β-adrenergic stimulation through its regulation of the sarcoplasmic reticulum (SR) Ca-ATPase [1]. The SR Ca-ATPase is the primary mediator of muscle relaxation in its role of active transport of cytosolic calcium ions into the SR lumen after each contractile event which is induced, in turn, by rapid release of calcium into the cytosol. As the limiting step in contractility, the resequestration of cytosolic calcium provides a major control point for both contractile function and calcium signaling events within the cell [2]. PLB is coexpressed with the SERCA2a isoform of the Ca-ATPase in cardiac, smooth, and slow-twitch skeletal muscle where the nonphosphorylated form of PLB acts an inhibitor of the CaATPase. Upon PLB phosphorylation at Ser 16 or Thr 17 , mediated in vivo by PKA or CaM-kinase II, respectively, relief of inhibition is manifest in increased rates of calcium transport with concomitant increased contractile rates.Alterations in PLB regulation of ca...